Treatment with an investigational new medicine to determine if it improves lung function and decreases the symptoms of patients with chronic obstructive pulmonary disease (COPD)
Official Title
Conditions
– Chronic Obstructive Pulmonary Disease
Study Type
Interventional
Study Design
Treatment
Further Details
Study Start
Eligibility & Criteria
Ages Eligible for Study: 18 Years and above, Genders Eligible for Study: Both Criteria Other specific inclusion/exclusion criteria may apply. In order to determine eligibility, further examination by the investigator is necessary. Inclusion Criteria:Clinical diagnosis of COPD (Chronic Obstructive Pulmonary Disease) Currently stable COPD with no change in COPD treatment in the prior 4 weeks Exclusion Criteria:Clinical diagnosis of asthma Poorly controlled COPD Regular need for daily oxygen therapy
Total Enrolment
Contact Details
[1] Pfizer[2] ALTANA PharmaAll content and media on the HealthEngine Blog is created and published online for informational purposes only. It is not intended to be a substitute for professional medical advice and should not be relied on as health or personal advice. Always seek the guidance of your doctor or other qualified health professional with any questions you may have regarding your health or a medical condition. Never disregard the advice of a medical professional, or delay in seeking it because of something you have read on this Website. If you think you may have a medical emergency, call your doctor, go to the nearest hospital emergency department, or call the emergency services immediately.
Related Articles
Need a health appointment?
Find and book a doctor, dentist, physio and more on Healthengine
Find a practitioner
